Similar neuroprotective effects from sodium-glucose cotransporter-2 inhibitors and dulaglutide
1. In this target trial emulation study of older adult patients with type 2 diabetes, those who received sodium-glucose cotransporter-2 inhibitors had a similar incidence of dementia versus those who received dulaglutide. 2. The two groups continued to have...